Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retro-Prospective Postmarket Clinical Study For FX Shoulder Solutions Long Cemented HUMELOCK II®

NCT07663552 is registered in ClinicalTrials.gov with FX Solutions as lead sponsor.

NCT NCT07663552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07663552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retro-Prospective Postmarket Clinical Study For FX Shoulder Solutions Long Cemented HUMELOCK II®
Lead sponsor
FX Solutions
Phase
Observational
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
June 30, 2037
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

humeral fracture, proximal, revision of a shoulder prosthesis